TriSalus Life Sciences Goodwill and Intangible Assets 2021-2025 | TLSI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TriSalus Life Sciences goodwill and intangible assets from 2021 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

TriSalus Life Sciences Goodwill and Intangible Assets 2021-2025 | TLSI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TriSalus Life Sciences goodwill and intangible assets from 2021 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229.7B
Boston Scientific (BSX)	$152.7B
Stryker (SYK)	$148.7B
EssilorLuxottica (ESLOY)	$131.4B
Medtronic (MDT)	$115.3B
Lonza Group Ag (LZAGY)	$49.7B
Haleon (HLN)	$44.7B
ResMed (RMD)	$37.3B
Agilent Technologies (A)	$35B
GE HealthCare Technologies (GEHC)	$34.4B
Terumo (TRUMY)	$24.6B
Koninklijke Philips (PHG)	$23.1B
Insulet (PODD)	$20.4B
Zimmer Biomet Holdings (ZBH)	$18.6B
Baxter (BAX)	$14.7B
Smith & Nephew SNATS (SNN)	$13.3B
Demant (WILYY)	$9B
Sunny Optical Technology (SNPTF)	$8.6B
Bio-Rad Laboratories (BIO)	$7B
Lantheus Holdings (LNTH)	$5.6B
Perrigo (PRGO)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.3B
QuidelOrtho (QDEL)	$2.1B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B